Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

Israel’s controversial Oscar submission gets snubbed on the 2022 Academy shortlist

LOS ANGELES (JTA) —  There was no holiday cheer for Israel’s filmmakers in the shortlists for the 2022 Academy Awards.

The country’s official submission for this year’s Best International Feature Oscar, “Let It Be Morning,” was not among the 15 entries that made the cut in the category, despite being helmed by a pedigreed director (Eran Kolirin, of “The Band’s Visit” fame) and attracting global attention for its all-Palestinian cast.

The movie, which won the Ophir Award (Israel’s equivalent to the Oscars) for best film for its depiction of life in Israel from a Palestinian perspective, generated controversy upon its debut at the Cannes Film Festival this year. Most of its Palestinian cast and crew did not attend the premiere, nor the Ophir awards ceremony, protesting the fact that the movie — based on a novel by the Arab Israeli author Sayed Kashua and financed primarily by Israeli producers — was being categorized as an Israeli film.

“Let It Be Morning” will be released in the United States in 2022.

In addition, a handful of high-profile Israeli documentaries missed out on the Best Documentary shortlist, including Maya Sarfaty’s “Love It Was Not,” about an unlikely romance between a Jewish prisoner of Auschwitz and an SS officer in the death camp, and Vanessa Lapa’s “Speer Goes To Hollywood,” about a Nazi architect’s attempts to reinvent himself after WWII. The latter had generated its own controversy for purportedly fictionalizing elements of key archival conversations.

The 94th Academy Awards will take place at the Dolby Theatre in Hollywood on March 27, 2022.


The post Israel’s controversial Oscar submission gets snubbed on the 2022 Academy shortlist appeared first on Jewish Telegraphic Agency.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.